AlzChem Group
XTRA:ACT Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 31 Fair Values set on narratives written by author
WA
Consensus Narrative from 5 Analysts
Expansion Of Nitroguanidine Production To Meet Defense Industry Demand Is Expected To Strengthen Market Position
Key Takeaways Strategic expansion in production capacities and collaboration with the U.S. Department of Defense could bolster long-term revenue and market diversification. Focus on specialty chemicals and a share buyback program can enhance profitability and earnings, boosting investor confidence and market visibility.
View narrative€75.74
FV
8.1% undervalued intrinsic discount6.96%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
4 days ago author updated this narrative